Pharmaceutical Benefits Advisory Committee (PBAC)

Company

Last mentioned: Feb 27, 2026

Timeline

  1. Public Advocacy Surge

    Increased media coverage and patient advocacy highlight the pricing disparity between genders.

  2. TGA Approval

    The Therapeutic Goods Administration approves the first female-specific testosterone cream.

  3. Global Consensus Statement

    International medical societies reach consensus on testosterone use for women's sexual health.

Stories mentioning Pharmaceutical Benefits Advisory Committee (PBAC) 1

regulation Neutral

Australia's Testosterone Gender Gap: Women Face Higher Costs for Vital Therapy

Australian women are facing significant financial barriers to accessing testosterone therapy, often paying substantially more than men for the same hormone treatment. While the therapy is clinically recognized for treating sexual dysfunction in postmenopausal women, the lack of subsidized options highlights a systemic gap in the national pharmaceutical framework.

2 sources